Last reviewed · How we verify
Papillary thyroid carcinoma
Approved treatments
- Lenvima · Eisai
Lenvima works by blocking the activity of a specific protein called Ret, which is involved in the growth and spread of cancer cells.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Papillary thyroid carcinoma patent landscape — cliff calendar, originator estates, attackable patents
- Papillary thyroid carcinoma treatment landscape brief
- Papillary thyroid carcinoma treatment updates RSS
Frequently asked questions about Papillary thyroid carcinoma
What drugs treat Papillary thyroid carcinoma?
Tracked treatments include Lenvima.
What is the treatment for Papillary thyroid carcinoma?
Standard treatment for Papillary thyroid carcinoma includes Lenvima. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Papillary thyroid carcinoma patent cliff · Papillary thyroid carcinoma CI report
- Treatment: Lenvima · Eisai
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing